Anika Therapeutics, Inc. (ANIK) NASDAQ
15.85
+0.48(+3.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.85
+0.48(+3.12%)
Currency In USD
| Previous Close | 15.37 |
| Open | 15.55 |
| Day High | 15.91 |
| Day Low | 15.55 |
| 52-Week High | 16.24 |
| 52-Week Low | 7.87 |
| Volume | 75,488 |
| Average Volume | 141,373 |
| Market Cap | 228.58M |
| PE | -22.64 |
| EPS | -0.7 |
| Moving Average 50 Days | 14.05 |
| Moving Average 200 Days | 10.65 |
| Change | 0.48 |
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference
GlobeNewswire Inc.
Feb 18, 2026 9:01 PM GMT
BEDFORD, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Steve Griffin, President and CEO of Anika, will present at the Ca
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:01 PM GMT
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2025 financial resu
Anika Therapeutics Announces Leadership Transition
GlobeNewswire Inc.
Jan 08, 2026 12:00 PM GMT
Stephen (Steve) Griffin, Current Chief Financial Officer and Chief Operating Officer, Appointed President and Chief Executive OfficerCheryl Blanchard to Become Executive Chair of the Board of Directors BEDFORD, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE)